Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Protein-Rich Frog Foam For Antibiotic Drug Delivery

XTALKS VITALS NEWS

Frog

The female frogs lay their eggs in the foam nests, which act as protective barrier against predators, environmental stresses, and microbial pathogens.

Share this!

March 24, 2016 | by Sarah Massey, M.Sc.

Sometimes innovations in drug delivery come from an unlikely source. Scientists from the University of Strathclyde in Scotland, have demonstrated the effectiveness of a proteinaceous foam made by Tungara frogs, as an antibiotic delivery system for infection prevention. The details of their research were presented yesterday at the Microbiology Society's Annual Conference in Liverpool.

Trinidadian Tungara frogs (Engystomops pustulosus) produce a novel protein substance when mating, which the frogs then whip into a foam with their hind legs. The female frogs lay their eggs in the foam nests, which act as protective barrier against predators, environmental stresses, and microbial pathogens.

In their analysis of the foam, the researchers found that the substance was able to carry a drug load in a stable manner, and release the pharmaceutical at a predictable rate. Using model dyes, the team demonstrated that the foam could steadily release the load over a period of 72 to 168 hours.

What’s more, when the researchers loaded vancomycin – an antibiotic – into the foam, it was able to prevent Staphylococcus aureus bacterial growth for 48 hours. Importantly, the foam was found to be non-toxic when exposed to skin cells for a 24 hour period – a result that could make the foam suitable for direct-to-skin application.



“Foams are usually very short-lived so they're not considered for long-term drug release, even though they have great potential for topical treatments,” said Sarah Brozio, a researcher on the study from the University of Strathclyde. “This foam comes from a tiny frog and yet offers us a whole new approach that could prevent wound infections, and with increasing antibiotic resistance it's important that all new tactics are explored.”

According to Brozio and her colleagues, the foam could be used for targeted drug delivery on specific areas of the body. In particular, patients with severe burns could benefit from the foam’s long-lasting release of antibiotics targeted toward the burn sight.

The researchers have already engineered E. coli to produce a recombinant version of the foam’s proteins, including Ranaspumin-2. They are also working towards making a fully synthetic version of the frog foam using an E. coli expression system.


Keywords: Antibiotics, Drug Delivery, Infection


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

READ THESE NEXT
Anthem Files Lawsuit Against Express Scripts Over Drug Pricing Dispute

March 23, 2016 - On Monday, health insurance company Anthem Inc. filed a lawsuit against their pharmacy benefit manager, Express Scripts, to reportedly recover damages due to pharmaceutical pricing and operations issues.


Breast Cancer Pill Illuminates Tumors, Leading To More Accurate Screening

March 22, 2016 - The pill contains a fluorescent dye that binds to cancer cells and fluoresces when exposed to near-infrared light.


Antibiotics Could Be Viable Treatment For Mild Appendicitis

March 22, 2016 - According to researchers at the University of Helsinki, patients with mild appendicitis who were treated with antibiotics do not have a higher risk of developing complications, within one year of starting treatment.

 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Brexit – Separating Fact from Fiction


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond


Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms


Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


Copyright © 2016-2017 Honeycomb Worldwide Inc.